Tobacco use is the #1 health problem and preventable cause of death in the U.S. Every year, more than 400,000 Americans die from smoking-related diseases. Smoking is associated with increased risk for at least 15 types of cancers, including those of the mouth, larynx, esophagus, pancreas, cervix and bladder; it is also a major cause of chronic lung diseases, heart disease and stroke. Smoking accounts for 30% of all cancer deaths and 87% of lung cancer deaths. The number of adolescents currently smoking is at least 4.5 million. According to the American Lung Association, if current U.S. tobacco use patterns persist, about one third of these children and adolescents will die prematurely from smoking-related disease. Clinicians need to investigate the effect they can have on preventing smoking and facilitating smoking cessation in the next generation of smokers — the adolescent population.
The goal of this program is to educate clinicians about how to reduce tobacco use in adolescents. After you study the information presented here, you will be able to —
- Describe the health impact of smoking.
- Identify factors that influence adolescents to smoke.
- Indicate strategies to prevent and eliminate teenage smoking.
This CE course is approved for respiratory therapists.
This program has been approved for 1 contact hour of Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care, 9425 N. MacArthur Blvd., Suite 100, Irving, TX 75063. AARC Sponsor Id. 9514012. This is a nontraditional course.
If you are a respiratory therapist, remember to give us your AARC member number when filling out your license number information.
Gannett Education is also approved by the Florida Board of Respiratory Care (provider #FBN 50-1489).
Course Originally Released on:
Date of Most Recent Review:
Course Termination/Update Date:
Unless stated above, the planners and authors of this course have declared no real or perceived conflicts of interest that relate to this educational activity. Gannett Education guarantees this educational activity is free from bias. There is no commercial or in-kind support provided for this online educational activity.
Please see CE Course Instructions to learn how to earn CE credit for this module. For successful completion of this course, learners must read the course, and complete a posttest and evaluation survey.
This CE activity does not include any unannounced information about off-label use of a product for a purpose other than that for which is approved by the Food and Drug Administration (FDA).
The approval status for this educational activity, granted by the AARC, does not expressly or implicitly confer AARC endorsement of the activity’s content.
This course completion will be electronically reported to CE Broker as required per Florida Statute 456.025(7). Click here to view your CE Broker transcript and check the status of your CE requirements with a FREE 7-day CE Broker trial subscription. It may take up to 24 hours for the course to appear on your CE Broker transcript.